Ekso Bionics SEC Filings

Ekso Bionics Holdings Inc. filings document material-event disclosures, financing arrangements, governance actions, capital-structure changes, and operating results for an exoskeleton technology issuer. The company’s Form 8-K disclosures include financial results, material agreements, shareholder voting matters, and security-structure information tied to preferred stock, warrants, and other corporate actions.

Regulatory filings also cover a private placement of Series B Convertible Preferred Stock and warrants, a secured term loan involving subsidiary Ekso Bionics, Inc. as guarantor, equity awards under the company’s Amended and Restated 2014 Equity Incentive Plan, and governance matters associated with the company’s corporate transition.